The AJRS, Allama Iqbal Medical College, and Jinnah Hospital present AIMSCon 2026, a national research conference open to undergraduate students in medicine and allied healthcare fields, scheduled for October 31, 2026 at Allama Iqbal Medical College.
To improve the likelihood of your abstract(s) being accepted, please read and follow all guidelines below before submitting.
1. Before You Submit
- Submission deadline: 26 September 2026 at 11:59 PM Pakistan time.
- The presenting author must be an undergraduate medical or allied-health student and must be available to present in person at AIMSCon 2026.
- You may save and edit a draft until you make the final submission. Final submission is permanent and cannot be edited online.
- A final submission may be withdrawn online only before staff triage begins. Withdrawal does not reopen the submission for editing.
2. Presentation and Publication Eligibility
Previously presented or published work may still be submitted to AIMSCon if it is fully disclosed in the submission form. It may be accepted for an oral or poster presentation, but publication in the JAIMC (Journal of Allama Iqbal Medical College) AIMSCon Supplement has additional eligibility requirements.
An accepted abstract will be eligible for publication in the Supplement only if it:
- is presented at AIMSCon 2026;
- has not previously been published as a conference abstract or full-text article; and
- is not currently under submission to a journal.
Only the abstract text will be published. Supplementary figures, tables, and videos are provided for reviewers' reference and will not appear in the published abstract.
3. Abstract Categories
Every abstract must be submitted under exactly one of the following three study-type categories. The category chosen does not affect scoring.
-
Original Research
- Cross-sectional/survey studies
- Case-control studies
- Prospective cohort studies
- Retrospective cohort studies
- Randomized controlled trials (RCTs)
- Diagnostic-accuracy studies
- Laboratory/bench research
- Medical-education research
- Research Methods and Methodological Innovations
- Quality-improvement (QI)/innovation projects
- Public-health/community-based studies
- CDC analysis papers
- Artificial Intelligence & Machine Learning (AI/ML) research
-
Review
- Systematic review and/or meta-analysis
-
Case Report / Case Series
- Case report
- Case series
4. Field / Specialty
Each abstract must also be tagged with the single medical field or specialty it best fits, selected from the list below:
If a submission spans more than one field, select the specialty most central to the research question.
5. Abstract Templates
Download the template for your category to see the information and section structure required by the online submission form:
The templates are planning aids only. Do not upload a completed template; enter the final abstract into the corresponding fields in the online submission portal.
6. Abstract Structure & Word Limit
Word limit: Maximum 400 words, excluding the title, author names, affiliations, keywords, and references.
Keywords: exactly 5, listed after the title, and all must be MeSH terms.
Follow the heading structure below, in order, matching your category:
7. Formatting Requirements
- Spell out the full term at first use before an abbreviation or acronym.
- Use generic (not brand) names for drugs and equipment.
- Numerals for all numbers ≥10; SI units preferred throughout.
- Maximum 3 references (excluded from word count), Vancouver style.
8. Ethics, Consent & Data Protection
- All patient/identifiable data must be fully anonymized; failure results in immediate rejection.
- Original Research and Reviews: state IRB/ERB/ERC approval (with reference number), the reason approval was not required, or that a waiver was granted.
- Case Reports/Series: include a statement confirming written informed consent from the patient, or from a guardian for pediatric or incapacitated patients.
- Systematic reviews are encouraged to report a prospective registration number (e.g., PROSPERO).
- RCTs should report a trial registration number where applicable (e.g., ClinicalTrials.gov).
9. Supplementary Material
- You may upload one optional, de-identified PDF containing up to one figure and/or one table (maximum 10 MB).
- Case Report / Case Series submissions may additionally upload one optional, de-identified MP4 supporting video (maximum 50 MB).
- Supplementary material is provided for reviewers' reference only and will not appear in the published abstract.
10. Authorship Details
There is no limit on the total number of co-authors. Enter each author separately and in the order in which the authors should appear on certificates and in publication. A full legal name, e-mail address, and institutional affiliation are required for every author; ORCID is optional.
Corresponding Author: exactly one, responsible for all communication. This is the person submitting the abstract and must be a co-author. Their name, e-mail address, phone number, and institution come from their AIMSCon profile and are read-only in the submission form. The corresponding author may also be the Presenting Author.
Presenting Author (PA): exactly one; must be a co-author on the abstract, an undergraduate medical or allied-health student, provide a phone number, and confirm in-person availability. Graduates are not eligible to present. An individual may be PA on multiple submissions but may present only one if several are accepted; another eligible author must be designated PA for the rest.
11. Declaration of AI Use
If any generative AI tool (e.g., ChatGPT, Claude, or similar) was used at any stage including drafting, language editing, data analysis, or figure generation, authors must declare the tool(s) used and their purpose. Routine spell-check is excluded. AI tools cannot be listed as an author; authors remain fully responsible for accuracy, originality, and integrity.
12. Originality, Attribution & Prior Publication
- Authors confirm the work is original and appropriately attributed; the Scientific Committee may investigate credible integrity concerns.
- Authors must disclose whether the abstract or study has previously been published and whether it is currently under submission to a journal. For either “Yes” answer, state where it was published or the journal to which it is under submission.
- Submission represents that authors hold rights to present the work and have permission from all co-authors.
13. Conflict of Interest & Funding Disclosure
- State any conflict of interest, or that none exists.
- Disclose funding source, or state that none was received.
14. Abstract Submission Process
- Save and review your draft before final submission. Ensure that all authors have approved the submitted version and that all supplementary material is de-identified.
- Final submission cannot be corrected or replaced online. If a final submission must be withdrawn before staff triage, use the withdrawal option in the student dashboard.
- An automated confirmation is sent to the corresponding author after successful final submission; contact the organizing committee at if none arrives within 48 hours.
15. Abstract Review & Presentation
All eligible abstracts undergo blinded scoring by two human reviewers from the AIMSCon 2026 Scientific Committee. Accepted abstracts are assigned oral or poster format at the Committee's sole discretion, communicated with results. AI is not used to make acceptance, rejection, presentation-format, scoring, or other conference decisions.
Authors may consent, in the submission form, to their de-identified abstract being screened retrospectively by AI after AIMSCon review is concluded for a future study of agreement between AI and blinded human reviewers. This research screening does not affect the conference review or outcome.
16. Contact
For any inquiries throughout the review process, please contact us at .